5-fluoro-N-methyl-6-[3-[4-(trifluoromethyl)phenyl]morpholin-4-yl]pyrimidin-4-amine;2-(3-fluoropiperidin-1-yl)acetamide
C23H29F5N6O2 — CID 156792438
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-fluoro-N-methyl-6-[3-[4-(trifluoromethyl)phenyl]morpholin-4-yl]pyrimidin-4-amine;2-(3-fluoropiperidin-1-yl)acetamide
5-fluoro-N-methyl-6-[3-[4-(trifluoromethyl)phenyl]morpholin-4-yl]pyrimidin-4-amine;2-(3-fluoropiperidin-1-yl)acetamide (PubChem CID 156792438) has the molecular formula C23H29F5N6O2 and a molecular weight of 516.52 g/mol. Its IUPAC name is 5-fluoro-N-methyl-6-[3-[4-(trifluoromethyl)phenyl]morpholin-4-yl]pyrimidin-4-amine;2-(3-fluoropiperidin-1-yl)acetamide.
Molecular Properties
| Compound Name | 5-fluoro-N-methyl-6-[3-[4-(trifluoromethyl)phenyl]morpholin-4-yl]pyrimidin-4-amine;2-(3-fluoropiperidin-1-yl)acetamide |
|---|---|
| PubChem CID | 156792438 |
| Molecular Formula | C23H29F5N6O2 |
| Molecular Weight | 516.52 g/mol |
| Exact Mass | 516.23 |
| IUPAC Name | 5-fluoro-N-methyl-6-[3-[4-(trifluoromethyl)phenyl]morpholin-4-yl]pyrimidin-4-amine;2-(3-fluoropiperidin-1-yl)acetamide |
| SMILES | CNc1ncnc(N2CCOCC2c2ccc(C(F)(F)F)cc2)c1F.NC(=O)CN1CCCC(F)C1 |
| InChI | InChI=1S/C16H16F4N4O.C7H13FN2O/c1-21-14-13(17)15(23-9-22-14)24-6-7-25-8-12(24)10-2-4-11(5-3-10)16(18,19)20;8-6-2-1-3-10(4-6)5-7(9)11/h2-5,9,12H,6-8H2,1H3,(H,21,22,23);6H,1-5H2,(H2,9,11) |
| InChIKey | HECCCNGQNJNKNL-UHFFFAOYSA-N |
| XLogP | 3.16 |
| TPSA | 96.61 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 516.52 |
| LogP ≤ 5 | 3.16 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156792438 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.